Herbal dipeptidyl peptidase-4 inhibitors for Alzheimer's disease
978-3-659-76250-5
3659762504
124
2015-07-27
54.90 €
eng
https://images.our-assets.com/cover/230x230/9783659762505.jpg
https://images.our-assets.com/fullcover/230x230/9783659762505.jpg
https://images.our-assets.com/cover/2000x/9783659762505.jpg
https://images.our-assets.com/fullcover/2000x/9783659762505.jpg
A growing body of evidence shows that pharmacological agents used for the treatment of type-2-diabetes such as dipeptidyl peptidase-4 inhibitors have become valuable candidates as disease modifying agents in the treatment of Alzheimer’s disease. This book deals with a study investigates the neuroprotective roles of Pterocarpus marsupium and Eugenia jambolana as dipeptidyl peptidase-4 inhibitors in streptozotocin induced Alzheimer's disease. Our finding suggests that Pterocarpus marsupium and Eugenia jambolana are the potential cognitive enhancers against streptozotocin induced Alzheimer's disease by dipeptidyl peptidase-4 inhibitory action and their neuroprotective action attributed through increase in active glucagon-like peptide-1 levels.
https://morebooks.de/books/es/published_by/lap-lambert-academic-publishing/47/products
Farmacia
https://morebooks.de/store/es/book/herbal-dipeptidyl-peptidase-4-inhibitors-for-alzheimer-s-disease/isbn/978-3-659-76250-5